Neuroscience
Polyneuropathy
100%
Neuropathic Pain
59%
Placebo
55%
Diabetic Neuropathy
52%
Neuropathy
49%
Intravenous Immunoglobulin
41%
Quantitative Sensory Testing
27%
Nerve Conduction Study
26%
Imipramine
19%
Nerve Fiber
18%
Cytochrome P450 2D6
17%
Peripheral Nerve
15%
Escitalopram
15%
Randomized Controlled Trial
14%
Pain Threshold
14%
Nerve Function
13%
Cerebrovascular Accident
13%
Tramadol
12%
Diabetes Mellitus
11%
Sparteine
10%
Immunotherapy
10%
Oxaliplatin
10%
Blood Plasma
9%
Hyperalgesia
9%
Sural Nerve
9%
Crossover Study
8%
Selective Serotonin Reuptake Inhibitor
8%
Nociceptor
8%
Neurological Disorder
7%
Pregabalin
7%
Statin
7%
Oxycodone
7%
Nerve Conduction
7%
Confocal Microscopy
7%
Pharmacokinetics
6%
Serotonergic
6%
Paroxetine
6%
Hyperglycemia
6%
Axonal Excitability
6%
Lacosamide
6%
Citalopram
6%
Electrodiagnosis
6%
Motor Unit
6%
Opiate
6%
Debrisoquine
6%
Morphine
5%
Peripheral Nerve Injury
5%
Oxcarbazepine
5%
Tricyclic Antidepressant
5%
Serotonin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
60%
Neuropathic Pain
44%
Sparteine
34%
Polyneuropathy
30%
Diabetic Neuropathy
25%
Syndrome
25%
CYP2D6
24%
Immunoglobulin
23%
Imipramine
23%
Codeine
21%
Chronic Inflammatory Demyelinating Polyneuropathy
20%
Morphine
19%
Paroxetine
17%
Pharmacokinetics
16%
Selective Serotonin Reuptake Inhibitor
15%
Randomized Controlled Trial
15%
Experimental Pain
14%
Analgesic Agent
14%
Levetiracetam
14%
Oxycodone
14%
Citalopram
13%
Tramadol
13%
Side Effect
12%
Escitalopram
12%
Pregabalin
12%
Anticonvulsive Agent
11%
Desipramine
9%
Tricyclic Antidepressant
8%
Infection
8%
Opiate
8%
Neuropathy
7%
Debrisoquine
7%
Lacosamide
7%
Postoperative Pain
7%
Motor Neuropathy
6%
Statin (Protein)
6%
Quinidine
6%
Clinical Trial
6%
Oxcarbazepine
6%
Drug Action
5%
Adverse Drug Reaction
5%
Medicine and Dentistry
Neuropathic Pain
57%
Polyneuropathy
55%
Diabetic Neuropathy
41%
Diagnosis
36%
Immunoglobulin
36%
Chronic Inflammatory Demyelinating Polyneuropathy
34%
Neuropathy
32%
Placebo
29%
Quantitative Sensory Testing
21%
Skin Biopsy
19%
Nerve Conduction Study
18%
Nerve Fiber
16%
Quality of Life
14%
Muscle Strength
11%
Analgesia
10%
Drug Therapy
9%
Randomized Controlled Trial
9%
Infection
8%
Pregabalin
8%
Side Effect
8%
Cross Sectional Study
8%
Maturity Onset Diabetes of the Young
8%
Prevalence
8%
Nociceptor
7%
Patient with Type 2 Diabetes
7%
Immunoglobulin M
7%
Disease
7%
Walk Test
7%
Lacosamide
7%
Chronic Pain
7%
Imipramine
7%
Confocal Microscopy
7%
Clinical Trial
6%
Excitability
6%
Oxaliplatin
6%
Immunotherapy
6%
Diabetes Mellitus
6%
Oxcarbazepine
6%
Numeric Rating Scale
6%
Anticonvulsant
5%
Physical Disease by Body Function
5%
Diabetes
5%
Odds Ratio
5%
Pain Threshold
5%
Patient Registry
5%
